Sacubitril/Valsartana em Doença de Chagas

 1. Bocchi EA, Echeverria LE, Demacq C, et al. Sacubitril/Valsartan Versus Enalapril in Chronic Chagas Cardiomyopathy: Rationale and Design of the PARACHUTE-HF Trial. JACC Heart Fail. 2024;12(8):1473-1486. 

2. Nanas JN, Alexopoulos G, Anastasiou-Nana MI, et al. Outcome of patients with congestive heart failure treated with standard versus high doses of enalapril: a multicenter study. High Enalapril Dose Study Group. J Am Coll Cardiol. 2000;36(7):2090-2095. 

3. Rindone JP, Mellen CK. Sacubitril/valsartan compared to equivalent/sub-equivalent dose angiotensin receptor blocker or angiotensin-converting enzyme inhibitor in heart failure with reduced ejection fraction: a meta-analysis of randomized trials. Eur J Clin Pharmacol. 2024;80(8):1113-1120. 

4. Khan MS, Fonarow GC, Ahmed A, et al. Dose of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcomes in Heart Failure: A Meta-Analysis. Circ Heart Fail. 2017;10(8):e003956.

Support the show

Este podcast é parte do nosso Programa de Educação Online em Medicina Baseada em Evidências:

Assinatura Curso Online de MBE: https://medicinabaseadaemevidencia.com.br
Link para Bio: https://medicinabaseadaemevidencia.com.br/bio

Cadastre seu email no link da Bio para receber atualizações de novo conteúdo no Canal do YouTube, Podcast, Blog e saber nos movimentos internos no Programa Online de MBE.